[PRNewswire] GenScript ProBio Establishes Korean Legal Entity and Further
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Strengthens Cooperation in South Korea and APAC Region
(NANJING, China, May 12, 2022 PRNewswire=연합뉴스) On the May 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO company from GenScript Biotech Corporation, today announced the opening of a legal entity in South Korea at the BIO KOREA 2022 International Convention. BIO KOREA 2022 International Convention is the biggest bio-health convention in Asia.
During the BIO KOREA 2022, Dr. Brian H. Min, CEO of GenScript ProBio, introduced the development history of GenScript ProBio to the participants and officially announced that GenScript ProBio established a legal entity in South Korea.
Since the establishment of GenScript Biotech Corporation and GenScript ProBio, they have been actively exploring in the field of bioprocessing and manufacturing, facilitating bio manufacturing excellence at enhanced speed, reduced cost, and superior quality to support the innovation plans of customers in South Korea, Asia Pacific and around the world, and GenScript ProBio has cooperated with several customers from Korea. With outstanding technical strength and high-quality CDMO services, GenScript Biotech Corporation received the "Best Contract Development and Manufacturing Organization Award" at the Asia Pacific Bioprocessing Excellence Awards 2022. This marks the third consecutive year of GenScript bagging the same award in the Asia Pacific region. The award also followed GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the 'Best Contract Development and Manufacturing Organization Award'.
"We are very pleased to announce the establishment of a legal entity called 'Genscript Probio Biotech Korea Ltd.' at the BIO KOREA conference", said Dr. Brian Min, CEO of GenScript ProBio. "South Korea is one of the most dynamic innovation centers of the biotech industry in the Asia-Pacific region. We are looking forward to working with scientists and partners in South Korea, utilizing GenScript ProBio's one-stop CDMO service platform from drug discovery to commercialization in cell and gene therapy, vaccine, biologics discovery and antibody protein drug, and are committed to improving human life and health."
About BIO KOREA International Convention
BIO KOREA International Convention has been held every year since 2006 and serves as a business platform for international bio health companies. Sponsored by the Ministry of Health and Welfare, BIO KOREA is a place of practical business correspondence as well as international information and technology exchange, invigorating the bio health industry. In its 17th year of bringing together various international academics, professionals, and CEOs of global bio health companies to obtain, exchange, and discuss diverse affairs, through exhibition, business forum, and conference. BIO KOREA has been providing abundant opportunities to assure competitive edges within the convergence industry centered around biotechnology.
www.biokorea.org
About GenScript ProBio
GenScript ProBio is the subsidiary of GenScript Biotech Corporation, proactively providing end-to-end CDMO service from drug discovery to commercialization with proactive strategies, professional solutions and efficient processes in cell and gene therapy, vaccine, biologics discovery and antibody protein drug to accelerate drug development for customers.
GenScript ProBio's total cell and gene therapy solution covers CMC of plasmid and virus for IND filing as well as clinical manufacturing and commercial manufacturing. GenScript ProBio's innovative solutions for biologics discovery and development include therapeutic antibody discovery, antibody engineering and antibody characterization. GMP capacity which meets FDA, EMA and NMPA regulatory requirements.
Toward the mission of "Innovation through Collaboration", GenScript ProBio is committed to helping customers shorten the timeline for the development of biological drugs from discovery to commercialization, significantly lowering R&D costs and building a healthier future.
https://www.genscriptprobio.com
Source: GenScript ProBio
[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
(끝)
출처 : PRNewswire 보도자료
Copyright © 연합뉴스 보도자료. 무단전재 및 재배포 금지.
- 정부, 대북 확성기 재개 논의한다…북 오물풍선 살포 대응 | 연합뉴스
- 한미 국방장관회담…'북 오물풍선, 정전협정 위반' 재확인(종합) | 연합뉴스
- "인류 최초 달 뒷면 토양 캐낸다"…'우주굴기' 中 창어6호 착륙(종합2보) | 연합뉴스
- 이종섭은 왜 '사단장 휴가·출근' 유독 챙겼나…증폭되는 의문 | 연합뉴스
- 정부, 종부세 '다주택 중과'부터 손질…중과-기본세율 일원화 | 연합뉴스
- 의대 '지방유학' 어디로…강원, 학생수 대비 지역인재 규모 1위(종합) | 연합뉴스
- [10대 도박의 덫] 석달간 3천만원 날리고 부모님 예물도 팔았다 | 연합뉴스
- 尹대통령, 탄자니아·에티오피아 정상과 회담 | 연합뉴스
- 22대 院구성 시한 닷새 앞인데…여야, 법사위·운영위 줄다리기만 | 연합뉴스
- 빚 많아 은행 재무평가받는 기업그룹 36곳 지정…쿠팡 등 추가 | 연합뉴스